Bioteque Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,135	2,073	1,945	2,010	1,825
Revenue Growth (YoY)	3.03%	6.58%	-3.26%	10.12%	-6.27%
Cost of Revenue	1,199	1,167	1,126	1,166	1,023
Gross Profit	936.94	905.08	818.94	844.54	802.87
Selling, General & Admin	193.36	185.65	168.32	196.19	186.11
Research & Development	73.3	76.26	70.44	69.98	68.83
Operating Expenses	266.66	261.91	238.76	266.17	254.94
Operating Income	670.28	643.17	580.18	578.38	547.93
Interest Expense	-7.54	-9.37	-11.6	-4.32	-1.9
Interest & Investment Income	15.35	13.53	10.97	2.14	0.73
Currency Exchange Gain (Loss)	-6.51	20.47	-11.55	33.77	-10.84
Other Non Operating Income (Expenses)	4.83	11.07	-1.64	3.57	5.18
EBT Excluding Unusual Items	676.41	678.87	566.35	613.53	541.11
Gain (Loss) on Sale of Investments	-1.79	5.44	3.16	9.65	-2.91
Gain (Loss) on Sale of Assets	-	-5.94	-	-	-
Pretax Income	674.62	678.37	569.52	623.18	538.2
Income Tax Expense	135.44	150.11	116.97	129.64	106.94
Net Income	539.19	528.26	452.55	493.54	431.26
Net Income to Common	539.19	528.26	452.55	493.54	431.26
Net Income Growth	2.07%	16.73%	-8.30%	14.44%	-11.75%
Shares Outstanding (Basic)	69	69	69	69	69
Shares Outstanding (Diluted)	70	70	70	70	70
Shares Change (YoY)	0.09%	0.01%	-0.03%	0.07%	0.01%
EPS (Basic)	7.78	7.62	6.53	7.12	6.22
EPS (Diluted)	7.74	7.59	6.50	7.09	6.20
EPS Growth	1.98%	16.77%	-8.32%	14.36%	-11.68%
Free Cash Flow	607	604.49	606.62	-82.25	-81.63
Free Cash Flow Per Share	8.71	8.68	8.71	-1.18	-1.17
Dividend Per Share	5.500	5.000	4.500	4.500	4.500
Dividend Growth	10.00%	11.11%	-	-	12.50%
Gross Margin	43.88%	43.67%	42.11%	42.01%	43.98%
Operating Margin	31.39%	31.03%	29.83%	28.77%	30.01%
Profit Margin	25.25%	25.49%	23.27%	24.55%	23.62%
Free Cash Flow Margin	28.43%	29.17%	31.19%	-4.09%	-4.47%
EBITDA	825.63	791.52	721.32	698.87	662.61
EBITDA Margin	38.66%	38.19%	37.09%	34.77%	36.30%
D&A For EBITDA	155.35	148.35	141.14	120.49	114.68
EBIT	670.28	643.17	580.18	578.38	547.93
EBIT Margin	31.39%	31.03%	29.83%	28.77%	30.01%
Effective Tax Rate	20.08%	22.13%	20.54%	20.80%	19.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.